These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 11232761
21. Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis? Scott LA, Kench PL. J Nucl Med Technol; 2004 Jun; 32(2):66-71. PubMed ID: 15175402 [Abstract] [Full Text] [Related]
22. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H. Jpn Circ J; 1995 Sep; 59(9):599-607. PubMed ID: 7500543 [Abstract] [Full Text] [Related]
23. Clinical use of metaiodobenzylguanidine imaging in cardiology. Merlet P, Piot O, Dubois-Randé JL, Loisance D, Castaigne A, Syrota A. Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746 [Abstract] [Full Text] [Related]
24. [Usefulness of myocardial imaging by 123I-MIBG in assessment of diabetic neuropathy]. Katono E, Owada K, Takeda H, Techigawara M, Watanabe N, Maruyama Y. Kaku Igaku; 1993 Oct; 30(10):1235-9. PubMed ID: 8264114 [Abstract] [Full Text] [Related]
25. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus. Tamura K, Utsunomiya K, Nakatani Y, Saika Y, Onishi S, Iwasaka T. Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830 [Abstract] [Full Text] [Related]
26. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, Noda T, Nishigaki K, Fujiwara H. J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607 [Abstract] [Full Text] [Related]
28. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Kim SJ, Lee JD, Ryu YH, Jeon P, Shim YW, Yoo HS, Park CY, Lim SG. Eur J Nucl Med; 1996 Apr; 23(4):401-6. PubMed ID: 8612660 [Abstract] [Full Text] [Related]
29. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Murata K, Sumida Y, Murashima S, Matsumura K, Takeda H, Nakagawa T, Shima T. Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849 [Abstract] [Full Text] [Related]
30. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Mäntysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Länsimies E, Uusitupa M. Clin Auton Res; 1996 Jun; 6(3):163-9. PubMed ID: 8832126 [Abstract] [Full Text] [Related]
31. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. Sacre JW, Franjic B, Coombes JS, Marwick TH, Baumert M. J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722 [Abstract] [Full Text] [Related]
32. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Schnell O, Muhr D, Weiss M, Kirsch CM, Haslbeck M, Tatsch K, Standl E. J Diabetes Complications; 1997 Mar; 11(5):307-13. PubMed ID: 9334913 [Abstract] [Full Text] [Related]
33. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy]. D'Alto M, Maurea S, Basso A, Varrella P, Polverino W, Bianchi U, Bonelli A, Salvatore M, Chiariello M. Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590 [Abstract] [Full Text] [Related]
34. Diabetic cardiac autonomic dysfunction: parasympathetic versus sympathetic. Uehara A, Kurata C, Sugi T, Mikami T, Shouda S. Ann Nucl Med; 1999 Apr; 13(2):95-100. PubMed ID: 10355953 [Abstract] [Full Text] [Related]
35. Prolonged lung retention of iodine-123-MIBG in diabetic patients. Unlü M, Inanir S. J Nucl Med; 1998 Jan; 39(1):116-8. PubMed ID: 9443749 [Abstract] [Full Text] [Related]
36. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Hoitsma E, Faber CG, van Kroonenburgh MJ, Gorgels AP, Halders SG, Heidendal GA, Kessels AG, Reulen JP, Drent M. Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):43-50. PubMed ID: 15881279 [Abstract] [Full Text] [Related]
37. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, Imamura H, Kinoshita O, Owa M, Fujii T. Am Heart J; 2002 Jul; 144(1):122-9. PubMed ID: 12094198 [Abstract] [Full Text] [Related]
38. The role of nuclear medicine technique in evaluating electrophysiology in diabetic hearts especially with 123I-MIBG cardiac SPECT imaging. Flotats A, Carrió I. Minerva Endocrinol; 2009 Sep; 34(3):263-71. PubMed ID: 19859048 [Abstract] [Full Text] [Related]